66 results
Page 2 of 4
424B3
et0t knjj2fc1tr7
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.3
8z0n6x
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
no1ic 0l7ysu
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
z9qbnv87a b24321
25 Apr 22
Prospectus supplement
5:02pm
424B3
8ko6dp
7 Apr 22
Prospectus supplement
4:46pm
S-3
79as71n sxo7kil
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.2
f25dmi1xy f027ws3a
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.1
gndbn81
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
whaao21 1ywuo
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
qsq85 jst0zc9q02fqi
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
ejpnqodvp34ggi
24 Sep 21
Annual report
7:31am
10-K
ub321jwqx7tpx5 01zwi
24 Sep 21
Annual report
7:31am
424B3
nsrz1hiqe
22 Jul 21
Prospectus supplement
10:27am